157 related articles for article (PubMed ID: 29540733)
1. Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4.
Wang L; Li JJ; Guo LY; Li P; Zhao Z; Zhou H; Di LJ
Oncogenesis; 2018 Mar; 7(3):26. PubMed ID: 29540733
[TBL] [Abstract][Full Text] [Related]
2. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
3. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.
Csibi A; Fendt SM; Li C; Poulogiannis G; Choo AY; Chapski DJ; Jeong SM; Dempsey JM; Parkhitko A; Morrison T; Henske EP; Haigis MC; Cantley LC; Stephanopoulos G; Yu J; Blenis J
Cell; 2013 May; 153(4):840-54. PubMed ID: 23663782
[TBL] [Abstract][Full Text] [Related]
4. Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis.
Yin X; Peng J; Gu L; Liu Y; Li X; Wu J; Xu B; Zhuge Y; Zhang F
Cell Death Dis; 2022 Nov; 13(11):955. PubMed ID: 36376267
[TBL] [Abstract][Full Text] [Related]
5. L-leucine stimulates glutamate dehydrogenase activity and glutamate synthesis by regulating mTORC1/SIRT4 pathway in pig liver.
Wang T; Yao W; He Q; Shao Y; Zheng R; Huang F
Anim Nutr; 2018 Sep; 4(3):329-337. PubMed ID: 30175263
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice.
Wang YS; Du L; Liang X; Meng P; Bi L; Wang YL; Wang C; Tang B
Hepatology; 2019 Apr; 69(4):1614-1631. PubMed ID: 30552782
[TBL] [Abstract][Full Text] [Related]
7. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.
Haigis MC; Mostoslavsky R; Haigis KM; Fahie K; Christodoulou DC; Murphy AJ; Valenzuela DM; Yancopoulos GD; Karow M; Blander G; Wolberger C; Prolla TA; Weindruch R; Alt FW; Guarente L
Cell; 2006 Sep; 126(5):941-54. PubMed ID: 16959573
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutamate dehydrogenase and insulin secretion by KHG26377 does not involve ADP-ribosylation by SIRT4 or deacetylation by SIRT3.
Kim EA; Yang SJ; Choi SY; Lee WJ; Cho SW
BMB Rep; 2012 Aug; 45(8):458-63. PubMed ID: 22917030
[TBL] [Abstract][Full Text] [Related]
9. Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potential.
Friday E; Oliver R; Welbourne T; Turturro F
J Cell Physiol; 2011 Feb; 226(2):511-9. PubMed ID: 20683912
[TBL] [Abstract][Full Text] [Related]
10. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic activation of secretory phenotypes in senescence by the FOXQ1-SIRT4-GDH signaling.
Sun X; Li Q; Tang Y; Hu W; Chen G; An H; Huang D; Tong T; Zhang Y
Cell Death Dis; 2023 Jul; 14(7):481. PubMed ID: 37516739
[TBL] [Abstract][Full Text] [Related]
12. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.
Chen Z; Lin J; Feng S; Chen X; Huang H; Wang C; Yu Y; He Y; Han S; Zheng L; Huang G
Onco Targets Ther; 2019; 12():2397-2408. PubMed ID: 30992675
[TBL] [Abstract][Full Text] [Related]
13. Glutaminolysis and insulin secretion: from bedside to bench and back.
Kelly A; Li C; Gao Z; Stanley CA; Matschinsky FM
Diabetes; 2002 Dec; 51 Suppl 3():S421-6. PubMed ID: 12475785
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.
Hu Y; Lin J; Lin Y; Chen X; Zhu G; Huang G
Oncol Lett; 2019 Feb; 17(2):2171-2176. PubMed ID: 30745932
[TBL] [Abstract][Full Text] [Related]
15. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling.
Zhao Z; Hao D; Wang L; Li J; Meng Y; Li P; Wang Y; Zhang C; Zhou H; Gardner K; Di LJ
Oncogene; 2019 Mar; 38(12):2076-2091. PubMed ID: 30442980
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia promotes mitochondrial glutamine metabolism through HIF1α-GDH pathway in human lung cancer cells.
Jiang ZF; Wang M; Xu JL; Ning YJ
Biochem Biophys Res Commun; 2017 Jan; 483(1):32-38. PubMed ID: 28065856
[TBL] [Abstract][Full Text] [Related]
18. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
Huang G; Cheng J; Yu F; Liu X; Yuan C; Liu C; Chen X; Peng Z
Oncol Rep; 2016 May; 35(5):2801-10. PubMed ID: 26986234
[TBL] [Abstract][Full Text] [Related]
19. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP.
Shen Y; Kapfhamer D; Minnella AM; Kim JE; Won SJ; Chen Y; Huang Y; Low LH; Massa SM; Swanson RA
Nat Commun; 2017 Sep; 8(1):624. PubMed ID: 28935892
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation.
Araujo L; Khim P; Mkhikian H; Mortales CL; Demetriou M
Elife; 2017 Jan; 6():. PubMed ID: 28059703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
